Literature DB >> 22872003

miRNA as activity markers in Parvo B19 associated heart disease.

U Kühl1, M Rohde, D Lassner, U M Gross, F Escher, H-P Schultheiss.   

Abstract

Parvovirus B19 is a frequent virus detected in endomyocardial biopsies of patients with clinically suspected myocarditis or dilated cardiomyopathy (DCM). Viruses often cause a more symptomatic disease with increased tissue injury if they become reactivated. A disease-specific differential expression of microRNAs (miRNAs) has been described in the regulation of replicating viruses. Analyzing patients with latent and reactivated B19V infection, we found 29 differentially regulated miRNAs and, in order to test whether predicted genes are differentially expressed, selected mRNAs were tested by TaqMan-QPCR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22872003     DOI: 10.1007/s00059-012-3656-3

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  35 in total

1.  Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy.

Authors:  M Noutsias; B Seeberg; H P Schultheiss; U Kühl
Journal:  Circulation       Date:  1999-04-27       Impact factor: 29.690

2.  Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural protein.

Authors:  Brian D Poole; Jing Zhou; Amy Grote; Adam Schiffenbauer; Stanley J Naides
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

3.  Endothelium-dependent flow-mediated vasodilation of systemic arteries is impaired in patients with myocardial virus persistence.

Authors:  Katja B Vallbracht; Peter L Schwimmbeck; Uwe Kühl; Bettina Seeberg; Heinz-Peter Schultheiss
Journal:  Circulation       Date:  2004-10-25       Impact factor: 29.690

4.  Phospholipase A2 activity-dependent stimulation of Ca2+ entry by human parvovirus B19 capsid protein VP1.

Authors:  Adrian Lupescu; C-Thomas Bock; Philipp A Lang; Susanne Aberle; Heike Kaiser; Reinhard Kandolf; Florian Lang
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

5.  Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance.

Authors:  Ali Yilmaz; Ingrid Kindermann; Michael Kindermann; Felix Mahfoud; Christian Ukena; Anastasios Athanasiadis; Stephan Hill; Heiko Mahrholdt; Matthias Voehringer; Michael Schieber; Karin Klingel; Reinhard Kandolf; Michael Böhm; Udo Sechtem
Journal:  Circulation       Date:  2010-08-16       Impact factor: 29.690

6.  Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue.

Authors:  Päivi Norja; Kati Hokynar; Leena-Maija Aaltonen; Renwei Chen; Annamari Ranki; Esa K Partio; Olli Kiviluoto; Irja Davidkin; Tomi Leivo; Anna Maria Eis-Hübinger; Beate Schneider; Hans-Peter Fischer; René Tolba; Olli Vapalahti; Antti Vaheri; Maria Söderlund-Venermo; Klaus Hedman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

Review 7.  Molecular pathology of inflammatory cardiomyopathy.

Authors:  Karin Klingel; Martina Sauter; C Thomas Bock; Gudrun Szalay; Jens-Jörg Schnorr; Reinhard Kandolf
Journal:  Med Microbiol Immunol       Date:  2003-08-14       Impact factor: 3.402

8.  Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells.

Authors:  Anja Duechting; Carsten Tschöpe; Heike Kaiser; Tobias Lamkemeyer; Nobuyuki Tanaka; Susanne Aberle; Florian Lang; Joseph Torresi; Reinhard Kandolf; C-Thomas Bock
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

9.  Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry.

Authors:  Kirsten A Weigel-Kelley; Mervin C Yoder; Arun Srivastava
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

10.  Let-7b is a novel regulator of hepatitis C virus replication.

Authors:  Ju-Chien Cheng; Yung-Ju Yeh; Ching-Ping Tseng; Sheng-Da Hsu; Yu-Ling Chang; Naoya Sakamoto; Hsien-Da Huang
Journal:  Cell Mol Life Sci       Date:  2012-03-06       Impact factor: 9.261

View more
  10 in total

1.  Nothing new in heart failure? A current misconception!

Authors:  B Maisch
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

2.  MicroRNA-20b suppresses the expression of ZFP-148 in viral myocarditis.

Authors:  Hong-Fei Xu; Xiang-Ting Gao; Jun-Yi Lin; Xue-Hua Xu; Jun Hu; Yu-Jie Ding; Shao-Hua Zhu
Journal:  Mol Cell Biochem       Date:  2017-02-28       Impact factor: 3.396

3.  Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients.

Authors:  Heinz-Peter Schultheiss; Thomas Bock; Heiko Pietsch; Ganna Aleshcheva; Christian Baumeier; Friedrich Fruhwald; Felicitas Escher
Journal:  J Clin Med       Date:  2021-04-29       Impact factor: 4.241

4.  Differential expression of micrornas in porcine parvovirus infected porcine cell line.

Authors:  Xinqiong Li; Ling Zhu; Xiao Liu; Xiangang Sun; Yuanchen Zhou; Qiaoli Lang; Ping Li; Yuhan Cai; Xiaogai Qiao; Zhiwen Xu
Journal:  Virol J       Date:  2015-08-20       Impact factor: 4.099

5.  Absent MicroRNAs in Different Tissues of Patients with Acquired Cardiomyopathy.

Authors:  Christine S Siegismund; Maria Rohde; Uwe Kühl; Felicitas Escher; Heinz Peter Schultheiss; Dirk Lassner
Journal:  Genomics Proteomics Bioinformatics       Date:  2016-07-28       Impact factor: 7.691

Review 6.  Viral myocarditis: a prime example for endomyocardial biopsy-guided diagnosis and therapy.

Authors:  Sophie Van Linthout; Carsten Tschöpe
Journal:  Curr Opin Cardiol       Date:  2018-05       Impact factor: 2.161

7.  GCAEMDA: Predicting miRNA-disease associations via graph convolutional autoencoder.

Authors:  Lei Li; Yu-Tian Wang; Cun-Mei Ji; Chun-Hou Zheng; Jian-Cheng Ni; Yan-Sen Su
Journal:  PLoS Comput Biol       Date:  2021-12-10       Impact factor: 4.475

Review 8.  Inflammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and Treatment.

Authors:  Jan Krejci; Dalibor Mlejnek; Dana Sochorova; Petr Nemec
Journal:  Biomed Res Int       Date:  2016-06-12       Impact factor: 3.411

Review 9.  Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era.

Authors:  S Greco; A Madè; C Gaetano; Y Devaux; C Emanueli; F Martelli
Journal:  J Transl Med       Date:  2020-10-31       Impact factor: 5.531

Review 10.  Cardiovascular consequences of viral infections: from COVID to other viral diseases.

Authors:  Heinz-Peter Schultheiss; Christian Baumeier; Heiko Pietsch; C-Thomas Bock; Wolfgang Poller; Felicitas Escher
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.